LT3558321T - Chinolinų dariniai kaip dyrk1a ir (arba) dyrk1b kinazių inhibitoriai - Google Patents

Chinolinų dariniai kaip dyrk1a ir (arba) dyrk1b kinazių inhibitoriai

Info

Publication number
LT3558321T
LT3558321T LTEPPCT/US2017/067527T LT17067527T LT3558321T LT 3558321 T LT3558321 T LT 3558321T LT 17067527 T LT17067527 T LT 17067527T LT 3558321 T LT3558321 T LT 3558321T
Authority
LT
Lithuania
Prior art keywords
dyrk1b
dyrk1a
quinolines
kinases
inhibitors
Prior art date
Application number
LTEPPCT/US2017/067527T
Other languages
English (en)
Inventor
Agnieszka DREAS
Charles-Henry Fabritius
Andrzej DZIENIA
Anna BUDA
Michal GALEZOWSKI
Georgiy KACHKOVSKYI
Urszula KULESZA
Katarzyna KUCWAJ-BRYSZ
Agnieszka SZAMBORSKA-GBUR
Wojciech Czardybon
Maria Vilenchik
Micheal FRID
Alexandra KUZNETSOVA
Original Assignee
Felicitex Therapeutics, Inc.
Ryvu Therapeutics S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Felicitex Therapeutics, Inc., Ryvu Therapeutics S.A. filed Critical Felicitex Therapeutics, Inc.
Publication of LT3558321T publication Critical patent/LT3558321T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
LTEPPCT/US2017/067527T 2016-12-23 2017-12-20 Chinolinų dariniai kaip dyrk1a ir (arba) dyrk1b kinazių inhibitoriai LT3558321T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16460096 2016-12-23
PCT/US2017/067527 WO2018119039A1 (en) 2016-12-23 2017-12-20 Derivatives of quinolines as inhibitors of dyrk1a and/or dyrk1b kinases

Publications (1)

Publication Number Publication Date
LT3558321T true LT3558321T (lt) 2023-05-10

Family

ID=57777491

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/US2017/067527T LT3558321T (lt) 2016-12-23 2017-12-20 Chinolinų dariniai kaip dyrk1a ir (arba) dyrk1b kinazių inhibitoriai

Country Status (6)

Country Link
US (1) US10577365B2 (lt)
EP (2) EP3558321B1 (lt)
JP (2) JP7134973B2 (lt)
LT (1) LT3558321T (lt)
PL (1) PL3558321T3 (lt)
WO (1) WO2018119039A1 (lt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3558321B1 (en) * 2016-12-23 2023-02-01 Felicitex Therapeutics, Inc. Derivatives of quinolines as inhibitors of dyrk1a and/or dyrk1b kinases
CN110483508B (zh) * 2019-08-29 2020-05-08 山东大学 化合物、制备方法及在制备GSK-3β抑制剂中的应用
CA3158150A1 (en) 2019-10-18 2021-04-22 The Regents Of The University Of California 3-phenylsulphonyl-quinoline derivatives as agents for treating pathogenic blood vessels disorders
KR20230003981A (ko) * 2021-06-30 2023-01-06 한국화학연구원 DYRK1 억제제인 피롤로[3,2-c]피리딘 유도체 및 이의 용도

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2480317A1 (en) 2002-03-28 2003-10-09 Eisai Co., Ltd. 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
US20070066641A1 (en) 2003-12-19 2007-03-22 Prabha Ibrahim Compounds and methods for development of RET modulators
GB0405055D0 (en) 2004-03-05 2004-04-07 Eisai London Res Lab Ltd JNK inhibitors
CA2560454C (en) 2004-03-30 2013-05-21 Vertex Pharmaceuticals Incorporated Azaindoles useful as inhibitors of jak and other protein kinases
WO2006063167A1 (en) 2004-12-08 2006-06-15 Smithkline Beecham Corporation 1h-pyrrolo[2,3-b]pyridines
WO2008005457A2 (en) 2006-06-30 2008-01-10 Sunesis Pharmaceuticals Pyridinonyl pdk1 inhibitors
AU2009322656A1 (en) * 2008-12-05 2010-06-10 Merck Sharp & Dohme Corp. Inhibitors of phosphoinositide dependent kinase 1 (PDK1)
EP2576549A4 (en) 2010-05-24 2013-12-18 Univ Rochester Bicyclic Heteroarylkinase Inhibitors and Methods of Use
SG10201505951VA (en) 2010-07-30 2015-08-28 Oncotherapy Science Inc Quinoline derivatives and melk inhibitors containing the same
US8362023B2 (en) 2011-01-19 2013-01-29 Hoffmann-La Roche Inc. Pyrazolo pyrimidines
CA2830780A1 (en) 2011-03-22 2012-09-27 Amgen Inc. Azole compounds as pim inhibitors
PT3141548T (pt) 2011-07-05 2020-07-10 Vertex Pharma Processos e intermediários para a produção de azaindóis
AU2012298510B2 (en) 2011-08-19 2016-10-27 Diaxonhit DYRK1 inhibitors and uses thereof
WO2014085795A1 (en) 2012-11-30 2014-06-05 University Of Rochester Mixed lineage kinase inhibitors for hiv/aids therapies
WO2016000615A1 (en) * 2014-07-02 2016-01-07 Sunshine Lake Pharma Co., Ltd. Heteroaryl compounds and pharmaceutical applications thereof
EP3558321B1 (en) * 2016-12-23 2023-02-01 Felicitex Therapeutics, Inc. Derivatives of quinolines as inhibitors of dyrk1a and/or dyrk1b kinases

Also Published As

Publication number Publication date
JP2020502252A (ja) 2020-01-23
EP3558321A4 (en) 2020-05-27
EP4183786A1 (en) 2023-05-24
JP2022166286A (ja) 2022-11-01
EP3558321B1 (en) 2023-02-01
WO2018119039A1 (en) 2018-06-28
JP7134973B2 (ja) 2022-09-12
EP3558321A1 (en) 2019-10-30
PL3558321T3 (pl) 2023-10-23
US10577365B2 (en) 2020-03-03
US20180179199A1 (en) 2018-06-28

Similar Documents

Publication Publication Date Title
IL287518A (en) Dual inhibitors of the vista and pd-1 pathways
IL263163A (en) Pyridines are converted as inhibitors of dnmt1
IL268994A (en) Isoquinolines as inhibitors of HPK1
IL261167A (en) Heteroaryl pad4 inhibitors
HK1259232A1 (zh) Menin-mll的取代抑制劑及其使用方法
EP3463343A4 (en) HETEROCYCLIC INHIBITORS OF PTPN11
EP3541932A4 (en) CRISPR-CAS9 INHIBITORS
EP3344039A4 (en) SMALL DYRK1A INHIBITORY MOLECULES AND USES THEREOF
EP3273966A4 (en) Inhibitors of cyclin-dependent kinases
EP3510040A4 (en) ECTONUCLEOTIDASE INHIBITORS AND METHODS OF USE
EP3558998A4 (en) ECTONUCLEOTIDASE INHIBITORS AND METHODS OF USE
IL279949A (en) Heterocyclic MCT4 inhibitors
IL259801A (en) ezh2 inhibitors and methods of using them
IL259796A (en) Aza-benzimidazole inhibitors of pad4
IL257061A (en) Inhibitors of ezh2
PL3313833T3 (pl) Związki i ich zastosowanie w charakterze inhibitorów transferazy n-mirystoilu
LT3558321T (lt) Chinolinų dariniai kaip dyrk1a ir (arba) dyrk1b kinazių inhibitoriai
EP3389664A4 (en) MTHFD2 CAFFEIN INHIBITORS AND USES THEREOF
PL3362450T3 (pl) N1 i n7-podstawione pochodne sybiriliny oraz ich zastosowania jako inhibitory nekroptozy komórkowej
EP3284746A4 (en) Preparation and use of kinase inhibitor
IL270703A (en) History of Reziquimod
HK1257486A1 (zh) 8-羥基喹啉衍生物的對映異構體及其合成
EP3676252C0 (en) DERIVATIVES AND COMPOSITION OF QUINOLEINE AND NAPHTHIRIDINE
IL266121A (en) A history of metamorphosed quinoxaline as an inhibitor of pfkfb
EP3525795A4 (en) PHENOTHIAZINE DERIVATIVES AND RELATED METHODS OF USE